Nov. 05, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company ...
Amsellem covers the Healthcare sector, focusing on stocks such as Alkermes, Supernus Pharmaceuticals, and Corcept Therapeutics. Optinose has an analyst consensus of Moderate Buy, with a price target ...
YARDLEY, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback